Introduction
In Type 1a glycogen storage disease (GSD1a), hepatic glucose-6-phosphatase (G6P-ase) is inactive resulting in major changes of systemic glucose metabolism both upstream and downstream of hepatic glucose-6-phosphate (G6P) (Bandsma et al., 2002a (Bandsma et al., , 2002b . The capacity to maintain plasma glucose levels during fasting is impaired because endogenous glucose cannot be synthesized from either glycogen or gluconeogenic precursors since G6P is a common intermediate for both pathways. Normally, when glucose release via the absorption of dietary carbohydrate is insufficient to meet systemic demand, the balance is supplied by the hydrolysis of hepatic G6P to glucose by glucose-6-phosphatase. In GSD1a patients, the lack of G6P-ase activity means that hepatic carbon fluxes that would normally be destined for glucose production are necessarily redirected to other pathways. Although G6P can be disposed as glycogen, the hydrolysis of glycogen to glucose-which is largely dependent on G6P-ase-is also blocked. This results in the characteristic overabundance of hepatic glycogen, which cannot be relieved by fasting glycogenolysis. Under these conditions, the capacity for converting G6P to glycogen on a daily basis is likely very small and can only account for a very minor portion of G6P flux that is normally destined for endogenous glucose production. 1 Under both fasting and fed conditions, a significant fraction of hepatic G6P and plasma glucose is derived from gluconeogenic carbons originating from the anaplerotic pathways of the Krebs cycle, with pyruvate being the principal precursor. Gluconeogenesis is considered to account for the majority of anaplerotic outflow from the Krebs cycle (Rognstad and Katz, 1977; Magnusson et al., 1991; Katz et al., 1993; Beylot et al., 1995) . Gluconeogenic flux is largely sustained by the conversion of pyruvate to phosphoenolpyruvate (PEP) via pyruvate carboxylase (PC) and phosphoenolpyruvate carboxykinase (PEP-ck). Pyruvate may also be oxidized to acetyl-CoA via pyruvate dehydrogenase (PDH) hence substrate competition between PC and PDH can potentially regulate the rate of pyruvate conversion to G6P (Beylot et al., 1995; Large and Beylot, 1999) . Another potential regulatory mechanism is the recycling of PEP to pyruvate via pyruvate kinase that completes a futile cycle (pyruvate-oxaloacetate-PEPpyruvate) (Rognstad and Katz, 1977; Magnusson et al., 1991; Jones et al., 1997; Diraison et al., 1998; She et al., 2003; Jin et al., 2005 ways: first by redirecting anaplerotic flux from all sources (including anaplerotic substrates that enter the Krebs cycle as 4 and 5-carbon skeletons, such as aspartate, glutamate and glutamine) to pyruvate, and second, by consuming ATP that could otherwise fuel gluconeogenesis. In GSD1a patients, gluconeogenesis is negligible; hence the carbon outflow that would normally be destined for glucose synthesis must either be attenuated by the mechanisms described or redirected into alternative disposal pathways.
To study hepatic G6P-ase and Krebs cycle fluxes, we designed a stable-isotope tracer study that is summarized in Fig. 1 . The procedure is non-invasive and can be accommodated into the cornstarch feeding regime of GSD1a patients. [U-
13 C]Glycerol was used as means of delivering 13 C into the hepatic triose-P pool. This substrate has some key advantages in that it is palatable and can be mixed with the cornstarch meal and is also efficiently extracted and metabolized by the liver. [U-13 C]Glycerol was accompanied by two xenobiotic agents, acetaminophen and phenylbutyric acid, designed to safely sample key hepatic metabolites as conjugates that are cleared into urine. Acetaminophen is metabolized to acetaminophen glucuronide with the glucuronide moiety derived from UDP-glucose (Hellerstein et al., 1986) . Phenylbutyric acid can undergo b-oxidation to phenylacetyl-CoA, which then combines with hepatic glutamine to form phenylacetylglutamine (PAGN) (Comte et al., 2002) . Hepatic glutamine is derived in part from the Krebs cycle intermediate a-ketoglutarate, hence the 13 C-enrichment distribution of acetyl-CoA and the Krebs cycle can be inferred from PAGN (Yang et al., 1993; Jones et al., 1998 Jones et al., , 2001 Diraison et al., 1999) . The 13 C-enrichment and isotopomer distributions of PAGN and acetaminophen glucuronide, as well as plasma glucose and lactate, can be quantified by 13 C NMR following simple extraction and purification procedures (Jones et al., 1998 (Jones et al., , 2001 . The relative activities of anaplerotic and oxidative Krebs cycle fluxes and the pyruvate futile cycle can then be derived from the 13 C-enrichment or isotopomer distribution of PAGN (Diraison et al., 1998; Jones et al., 1998 Jones et al., , 2001 ).
Methods

Human studies
Five patients with Type 1a glycogen storage disease (3M, 2F; 1476 yr; 3579 kg) and 5 controls (1M, 4F; 2074 yr; 53713 kg) were studied following informed consent. For those subjects under 18 years old, informed consent was obtained from the parents. All GSD1a patients were on cornstarch therapy, receiving 1 g/kg of cornstarch every 3 h. The tracer study was incorporated into a set of four cornstarch meals spanning 9 h (Fig. 2) . With the second cornstarch meal, subjects ingested 500 mg acetaminophen and with the third meal, subjects ingested 200 mg phenylbutyric acid and 1 g [U-
13 C]glycerol. Immediately before the final cornstarch meal, 15 ml venous blood was drawn and immediately centrifuged. Plasma was removed and frozen until further processing. Urines were collected over 3-h periods as shown.
Processing of urinary metabolites and plasma glucose
Urine samples were adjusted to pH 7.0 and incubated overnight with 10,000 U of urease per sample. A trace of sodium azide was also added to inhibit possible infection from airborne microorganisms. The samples were then depleted of protein by addition of perchloric acid, followed by neutralization, centrifugation and lyophilization. Upon reconstitution in 2-3 ml water, the pH was adjusted to 8.0, the sample loaded on to a 16-ml Dowex-1 Â8-acetate column and washed with 25 ml of water. PAGN and acetaminophen glucuronide were eluted with 35 ml of 10 M acetic acid. This fraction was evaporated and re-suspended in 0.5-1.0 ml water. The pH was adjusted to 7.0 with NaOH, and the samples were centrifuged in Eppendorf tubes. A total of 0.5 ml of the supernatant was introduced into a 5-mm NMR tube and 0.1 ml of deuterated acetonitrile was added to provide a deuterium fieldfrequency lock signal. Plasma was depleted of protein, neutralized, centrifuged and lyophilized. The lyophilized extract was suspended in 0.6 ml deuterated water and centrifuged, and the supernatant transferred into a 5 mm NMR tube for NMR analysis.
NMR spectroscopy
Proton-decoupled 13 C NMR spectra were acquired at 11.75 T with a Varian Unity 500 system equipped with a 5-mm broadband ''switchable'' probe with z-gradient (Varian, Palo Alto, CA). Spectra were obtained at 50 1C. An acquisition time of 2 s and inter-pulse delay of 1 s were used and the number of acquisitions ranged from 5000 to 25,000. The relative areas of 13 C NMR multiplets were quantified using the curve-fitting routine supplied with the NUTS PC-based NMR spectral analysis program (Acorn NMR Inc., (Landau et al., 1996) ; and (3) oxidative pentose phosphate pathway flux relative to those of gluconeogenesis or glycolysis flux is assumed to be negligible (Magnusson et al., 1988) .
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Fractional contribution of G6P hydrolysis to plasma glucose
The singlet signal of each resonance was assumed to represent the natural abundance 13 C-enrichment of 1.11%. 13 C-Excess enrichment in carbons 6 of glucose was estimated from the total area of the 13 C-13 C spin-spin coupled doublet relative to the central singlet multiplied by 1.11%. Both a and b carbon 6 signals were analyzed. 13 C-Excess enrichment in carbon 6 of hepatic G6P
was estimated from the glucuronide carbon 6 resonance, which was also resolved into singlet and 13 C-
13
C spin-spin coupled doublet components. Assuming that all glucose excess 13 Cenrichment of carbon 6 was derived from carbon 6 of hepatic G6P, the fraction of plasma glucose derived from G6P was estimated as follows:
2.4.3. PAGN 13 C-isotopomer analysis and hepatic Krebs cycle fluxes 13 C-isotopomers and positional enrichments of the glutamine moiety of PAGN were quantified from the 13 C NMR multiplet signals. The singlet signal of each resonance was assumed to represent the natural abundance 13 C-enrichment of 1.11%. 13 CExcess enrichment in each of the five glutamine carbons was estimated from the total area of the 13 C-13 C spin-spin coupled multiplets relative to the central singlet multiplied by 1.11%. Glutamine 13 C-isotopomer ratios were quantified from resolved 13 C-13 C spin-spin coupled multiplet components of each resonance. 13 C-Excess enrichment and 13 C-isotopomer ratios were applied to tcaCALC (Malloy et al., 1990 ), a program developed by Dr Mark Jeffrey of the Advanced Imaging Research Center at the University of Texas Southwestern Medical Center at Dallas which is available for download at http://www.utsouthwestern.edu/ utsw/home/research/AIRC. There was total of 10 input variables: glutamine carbon 1-4 excess enrichment levels and the following six glutamine 13 C-multiplet ratios; carbon 1 doublet/singlet, carbon 2 1,2,3-13 C 3 -quartet/singlet, carbon 2 1,2-13 C 2 -doublet/ singlet, carbon 2 2,3-13 C 2 -doublet/singlet, carbon 3 doublet/ singlet and carbon 4 doublet/singlet. The 13 C NMR isotopomer data were fitted to a standard model of the hepatic Krebs cycle shown in Fig. 1 . 13 
Results
Glucose synthesis from hepatic G6P
In the 13 C NMR spectrum, 13 C-enrichment of glucuronide or glucose from [U- 13 C] glycerol is resolved from the background natural abundance 13 C signal as a result of 13 C-13 C spin-spin coupling. As illustrated in Fig. 3 , the glucuronide carbon 6 resonance has a singlet signal reflecting the natural abundance 13 C and a doublet arising from 13 also have doublet components reflecting the conversion of [4, 5, [6] [7] [8] [9] [10] [11] [12] [13] C 3 ]G6P to [4, 5, [6] [7] [8] [9] [10] [11] [12] [13] C 3 ]glucose. Since 13 C-enriched glucose can only be derived from 13 C-enriched G6P, the excess enrichments of plasma glucose relative to that of glucuronide directly reflects the fraction of plasma glucose derived from hepatic G6P. In control subjects, the 13 C-signals of both urinary glucuronide and plasma glucose were enriched with 13 C indicating hepatic metabolism of [U-13 C]glycerol to glucose, as shown in Table 1 . In healthy subjects, the fraction of plasma glucose derived from hepatic G6P-ase had a wide inter-individual range 20-50%, possibly reflecting differences in the absorption of unlabeled glucose coupled with variable suppression of hepatic glucose production during the meal. In comparison, GSD1a patients had a significantly reduced level of glucuronide 13 C-enrichment and no detectable plasma glucose 13 C-enrichment. The absence of excess plasma glucose 13 C-enrichment confirms that no plasma glucose was derived from hepatic G6P in any of the five patients. The reduced levels of glucuronide enrichment suggest that flux from G6P to UDP-glucose was lower in these patients compared to healthy controls. The possibility that reduced glucuronide enrichment could reflect reduced uptake and metabolism of [U- 13 represented in the carbon 2 multiplet). Fig. 4 shows the 13 C resonances of carbons 2, 3 and 4 from a healthy subject and GSD1a patient 1, who had no detectable 13 C-enrichment of glucose or glucuronide. The presence of significant levels of glutamine carbon 4 enrichment (see Table 2 ), invalidates the estimation of anaplerotic, pyruvate recycling and gluconeogenic fluxes directly from the carbon 2 multiplet ratios (Jones et al., 1997) . Nevertheless, inspection of the multiplets and 13 Cisotopomer ratios provides some qualitative information on the hepatic flux profiles. 
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1998, 2001). Metabolic flux analysis by tcaCALC is summarized in Fig. 5 and the flux outputs reflect the qualitative metabolic profile gleaned from inspection of the PAGN 13 C-multiplets. In control subjects, about one-third of acetyl-CoA utilized by the Krebs cycle was derived from pyruvate oxidation via pyruvate dehydrogenase (PDH). The fractional contribution of PDH flux to the acetyl-CoA pool was significantly higher in the GSD1a subjects, accounting for over one-half of acetyl-CoA generation. This difference in PDH flux contribution to acetyl-CoA is evident by a greater intensity of the carbon 4 doublet signal relative to that of carbon 3 for GSD1a patients, as illustrated by the spectra in Fig. 4 . This reflects a higher abundance of [4,5-13 C 2 ]glutamine relative to the other 13 Cisotopomers in GSD1a subjects compared to controls (see Table 2 ). In the metabolic model of the Krebs cycle, [U- 13 Table 3 ) as estimated by MonteCarlo simulations. In healthy subjects, flux through pyruvate carboxylase, PEPcarboxykinase and pyruvate kinase, constituting the pyruvate cycling pathway, was an order of magnitude higher than the oxidative Krebs cycle flux indicating high pyruvate cycling activity (Jones et al., 1997 (Jones et al., , 1998 (Jones et al., , 2001 ). Net anaplerotic outflow was about 1.5 times that of oxidative Krebs flux and amounted to $10% of the pyruvate cycling activity. In GSD1a subjects, pyruvate cycling fluxes were even higher than those of controls. Despite the blockage of gluconeogenic outflow, net anaplerotic fluxes also tended to be higher in GSD1a patients, amounting to about twice that of oxidative Krebs cycle flux. These results need to be interpreted with caution since the anaplerotic and pyruvate kinase flux estimates of each subject were associated with larger confidence intervals ($50-150% of the flux values, see Table 3 ) compared with those obtained for pyruvate oxidation flux. There are two reasons for this: first, the 13 C-glutamine isotopomers that define anaplerotic and pyruvate cycling fluxes, notably [1,2-13 C 2 ]glutamine and [1,2,3-13 C 3 ]glutamine, were present in low abundance as seen by their respective D12 and Q signals in the carbon 2 resonance of Fig. 4 . Thus, the quantification of these signals was less certain compared to those from other 13 C- isotopomers. Moreover, a sensitivity analysis performed with tcaSIM 2 to determine the unit change in anaplerotic and pyruvate recycling fluxes in response to changing the 13 C NMR multiplet ratios revealed that these relative flux estimates are quite sensitive to small errors in the D12 and Q multiplet contributions (data not shown).
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Enrichment of plasma and urinary lactate from [U-13 C]glycerol
Plasma lactate was enriched with 13 C in both healthy and GSD1a subjects. Significant levels of urinary lactate were detected by 1 H and 13 C NMR in three of the five GSD1a patients while none was detected in healthy subjects. For the three GSD1a patients that had urinary lactate, the carbon 2 and 3 13 C-signals had similar 13 C NMR multiplet structures to those of plasma lactate indicating that urinary lactate was also enriched from [U-
13 C]glycerol. In healthy subjects, plasma lactate levels relative to glucose were 0.3070.06, as assessed by the natural abundance 13 C-lactate/ 13 Cglucose signal ratios. In GSD1a patients, the plasma lactate to glucose ratio was 1.6371.33 reflecting a much higher availability of lactate relative to glucose as an oxidizable substrate for peripheral tissues. In healthy subjects, 13 C-enrichment levels of plasma lactate carbon 3 were estimated to be 0.670.3%. These values correspond to the carbon 6 enrichment levels of plasma glucose 3 and are consistent with Cori cycle activity where plasma lactate is derived from peripheral tissue glycolysis of endogenous glucose. In GSD1a patients, plasma and urinary lactate were also enriched with 13 C. Plasma lactate carbon 3 enrichment levels were 0.470.2%, slightly lower than that of control subjects. However, given the high plasma lactate concentrations and the additional lactate recovered in urine in GSD1a patients, this level of 13 Cenrichment represents a much larger mass conversion of [U-13 C]glycerol to 13 C-lactate compared to that of healthy control subjects. Since plasma glucose was not enriched with 13 C in the GSD1a patients, the 13 C-lactate enrichment could not have been derived from plasma glucose via the Cori cycle but instead must have been directly derived from the liver. The plasma lactate isotopomer distribution, as shown in Fig. 6 
Discussion
In this study, the complete block of carbon flow from hepatic intermediary metabolites to glucose in GSD1a patients was confirmed using a gluconeogenic tracer. In previous metabolic tracer studies of GSD1 children, [U- 13 C]glucose was given by nasogastric infusion and plasma glucose was analyzed for 13 Cisotopomers (Kalderon et al., 1988 (Kalderon et al., , 1989 . Under normal conditions, metabolism of infused [U- 13 C]glucose generates a population of partially labeled 13 C-glucose molecules through the recycling of 13 C-tracer via glycolysis, hepatic gluconeogenesis and glucose production (Tayek and Katz, 1996) . In GSD1a patients, these isotopomers were not detected, consistent with the absence of hepatic glucose production from G6P. In these studies, plasma lactate was enriched with 13 C and in addition to [U-13 C]lactate derived by simple glycolysis, lactate 13 C-isotopomers containing one or two 13 C atoms were also detected. These latter isotopomers are generated during passage of the [U-13 C]pyruvate moiety through the anaplerotic pathways of the hepatic Krebs cycle. While these studies provide evidence for blocked hepatic glucose production and the involvement of the hepatic Krebs cycle in the synthesis of 13 C-lactate from [U-13 C]glucose, the 13 C-isotopomer information from plasma glucose and lactate is not sufficient for describing specific hepatic Krebs cycle fluxes. In current models of human hepatic intermediary metabolism, gluconeogenesis is assumed to be the main pathway for anaplerotic carbon outflow from the hepatic Krebs cycle (Magnusson et al., 1991; Esenmo et al., 1992; Landau et al., 1993; Large et al., 1997; Diraison et al., 1998; Jones et al., 2001; Burgess et al., 2003) . This assumption is based on the fact that under most conditions, gluconeogenic flux is much higher than other potential net outflow fluxes from the hepatic Krebs cycle, such as amino acid or citrate synthesis. Although several independent studies have focused on quantifying human gluconeogenic and oxidative hepatic Krebs cycle fluxes from the labeling distribution of hepatic glutamine from a gluconeogenic tracer, estimates of human gluconeogenic outflow relative to oxidative Krebs cycle activity (i.e. flux through citrate synthase) remain highly uncertain, possibly because of systematic methodological biases in the determination of hepatic Krebs cycle fluxes with different tracers and analytical techniques. Based on the incorporation of [3-
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14 C]lactate tracer into carbons 1-5 of PAGN, Magnusson et al. (1991) estimated that gluconeogenic fluxes were 2-3 times that of citrate synthase flux. These relative flux ratios were similar between 60-h fasted subjects and overnight-fasted subjects given a glucose load. In a stable-isotope study using [3- 13 C]lactate and analysis of positional 13 C-enrichment in PAGN by gas chromatography-mass spectrometry, gluconeogenic fluxes were estimated to be $0.5 times those of citrate synthase flux in overnight-fasted healthy subjects (Diraison et al., 1998) . Jones et al. (1998 Jones et al. ( , 2001 reported gluconeogenic flux values that were approximately equal to citrate synthase flux in overnight-fasted subjects and $1.4 times citrate synthase flux in 24-h fasted subjects using [U- 13 C] propionate as a gluconeogenic tracer and 13 C NMR analysis of PAGN (). Estimates of pyruvate recycling fluxes based on phenylacetylglutamine labeling from [3- 13 C] or [3-14 C]lactate tracers, are typically smaller than those derived from this study or in previous studies using [U- 13 C] propionate (Jones et al., 1998 (Jones et al., , 2001 ).
Pyruvate recycling fluxes of 4 times citrate synthase flux were reported in 60-h fasted healthy subjects infused with [3-14 C]lactate (Magnusson et al., 1991) while for overnight-fasted subjects infused with [3-13 C]lactate, pyruvate recycling flux was estimated to be $2 times citrate synthase flux (Diraison et al., 1998 are also subject to high uncertainty because they require quantification of 13 C-enrichment or 14 C-specific activity in carbon 5 relative to carbons 2 and 3 of phenylacetylglutamine. Under most conditions, carbon 5 labeling from these tracers is very low relative to the other positions and small errors in the measurement of carbon 5 labeling propagate large errors in pyruvate recycling flux estimates. The metabolic model assumes metabolic and isotopic steadystate conditions. To the extent that the 13 C-enrichment levels of triose phosphate and pyruvate were varying over time as the 13 Cglycerol tracer was taken up by the liver and then consumed, a constant precursor 13 C-enrichment level was not maintained in our study. For both control and GSD1a subjects, the sampling period represented the peak 13 C-enrichment levels of glucuronide and phenylacetylglutamine; i.e. 13 C-enrichment levels for these metabolites were less for urine samples collected before or after this interval (data not shown). Under metabolic steady-state conditions the Krebs cycle flux parameters are relatively insensitive to slow changes in 13 C-precursor enrichment (Jones et al., 1998) hence these values are not expected to be significantly influenced by washing-in and out of the 13 C-label. We surmise that the 3-hourly cornflour ingestion regime maintained a relatively constant source of absorbed carbohydrate and hepatic metabolic state, but we acknowledge that other settings such as an insulin/glucose clamp protocol could provide more precise metabolic and endocrine control.
Hepatocyte intermediary metabolism is characterized by high activities of anaplerotic enzymes such as pyruvate carboxylase, the capacity to utilize a wide range of anaplerotic substrates, and an abundance of these substrates in the portal vein flow. Our results with GSD1a patients suggest that a restriction in gluconeogenic flux imposed from the top down results in a significant redistribution of carbon fluxes at the level of the hepatic Krebs cycle. These include an increased recruitment of acetyl-CoA from pyruvate relative to fatty acid oxidation and increased pyruvate recycling fluxes. These alterations are accompanied by predictable changes in the 13 C-isotopomer distribution of hepatic glutamine. In contrast, a change in the destination of anaplerotic outflow has no effect on the glutamine 13 C-isotopomer distribution and is therefore undefined by glutamine 13 Cisotopomer analysis. Thus, while relative anaplerotic fluxes in GSD1a patients were similar to those of healthy controls, the principal destination of anaplerotic carbons in GSD1a patients was lactate instead of G6P. As a result, gluconeogenic flux was decoupled from net anaplerotic outflow. In healthy subjects, the extent to which anaplerotic efflux is diverted from gluconeogenesis to lactate production is difficult to resolve by the analysis of lactate 13 C-enrichment from 13 C-tracers of the hepatic Krebs cycle. This is because plasma lactate can become enriched with 13 C via the Cori cycle (i.e. via gluconeogenesis, hepatic glucose production and peripheral tissue glycolysis) as well as by direct anaplerotic outflow from the hepatic Krebs cycle. The utilization of acetyl-CoA by lipogenesis provides another means for the non-oxidative disposal of carbon from the hepatic Krebs cycle pool. While de novo lipogenesis fluxes are relatively small in comparison to Krebs cycle and gluconeogenic fluxes in healthy subjects, in the few studies performed on GSD1a subjects, de novo lipogenesis rates of up to 40 times that of healthy controls were reported (Bandsma et al., 2002a (Bandsma et al., , 2002b . If the removal of acetyl-CoA for lipogenesis is compensated by an increase in acetyl-CoA production from pyruvate, oxidative Krebs cycle fluxes will not be changed. Therefore, in the absence of an independent measurement of lipogenesis or pyruvate oxidation, it is not possible to quantify the lipogenic recruitment of acetyl-CoA from the analysis of glutamine 13 C-isotopomers. Finally, there is the possibility that while relative anaplerotic fluxes were similar between healthy and GDS1a patients, absolute anaplerotic fluxes might differ if there was a systematic difference in absolute hepatic Krebs cycle fluxes between the two groups. To resolve this would require an independent measure of oxidative hepatic Krebs cycle activity, such as hepatic oxygen consumption or urea production. In summary, our studies demonstrate that in GSD1a patients, Krebs cycle fluxes are redirected to dispose carbon that would normally be used for glucose synthesis. The redirection of anaplerotic flux from gluconeogenesis to lactate production may be an important part of this adaptation. This mechanism could also play a role in the regulation of gluconeogenesis in healthy ARTICLE IN PRESS subjects. The decoupling of gluconeogenic flux from anaplerotic outflow implies that under certain conditions, absolute hepatic Krebs cycle fluxes may need to be evaluated independently of absolute gluconeogenic fluxes.
